vs

Side-by-side financial comparison of CareCloud, Inc. (CCLD) and Esquire Financial Holdings, Inc. (ESQ). Click either name above to swap in a different company.

Esquire Financial Holdings, Inc. is the larger business by last-quarter revenue ($40.5M vs $34.4M, roughly 1.2× CareCloud, Inc.). Over the past eight quarters, CareCloud, Inc.'s revenue compounded faster (15.1% CAGR vs 15.0%).

CareCloud, Inc. is a publicly traded American healthcare information technology company that provides services, to healthcare providers and hospitals. The Company maintains its headquarters in Somerset, New Jersey, and employs approximately 4,000 workers worldwide.

Esquire Financial Holdings, Inc. is a U.S.-headquartered bank holding company that provides comprehensive commercial and consumer banking products and services. Its core offerings include deposit accounts, business loans, mortgage services, and wealth management solutions, primarily serving small to medium enterprises, legal industry professionals, and local retail clients.

CCLD vs ESQ — Head-to-Head

Bigger by revenue
ESQ
ESQ
1.2× larger
ESQ
$40.5M
$34.4M
CCLD
Faster 2-yr revenue CAGR
CCLD
CCLD
Annualised
CCLD
15.1%
15.0%
ESQ

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CCLD
CCLD
ESQ
ESQ
Revenue
$34.4M
$40.5M
Net Profit
$12.2M
Gross Margin
Operating Margin
9.1%
Net Margin
30.2%
Revenue YoY
21.9%
Net Profit YoY
7.0%
EPS (diluted)
$0.06
$1.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCLD
CCLD
ESQ
ESQ
Q1 26
$40.5M
Q4 25
$34.4M
$39.4M
Q3 25
$31.1M
$37.6M
Q2 25
$27.4M
$35.8M
Q1 25
$27.6M
$33.8M
Q4 24
$28.2M
$33.1M
Q3 24
$28.5M
$31.9M
Q2 24
$28.1M
$30.6M
Net Profit
CCLD
CCLD
ESQ
ESQ
Q1 26
$12.2M
Q4 25
$13.5M
Q3 25
$3.1M
$14.1M
Q2 25
$2.9M
$11.9M
Q1 25
$1.9M
$11.4M
Q4 24
$11.8M
Q3 24
$3.1M
$11.4M
Q2 24
$1.7M
$10.5M
Operating Margin
CCLD
CCLD
ESQ
ESQ
Q1 26
Q4 25
9.1%
44.3%
Q3 25
10.3%
46.5%
Q2 25
10.9%
42.5%
Q1 25
7.3%
45.9%
Q4 24
12.2%
47.4%
Q3 24
11.4%
48.8%
Q2 24
8.1%
46.9%
Net Margin
CCLD
CCLD
ESQ
ESQ
Q1 26
30.2%
Q4 25
34.2%
Q3 25
9.8%
37.4%
Q2 25
10.6%
33.2%
Q1 25
7.0%
33.8%
Q4 24
35.6%
Q3 24
10.9%
35.6%
Q2 24
6.0%
34.3%
EPS (diluted)
CCLD
CCLD
ESQ
ESQ
Q1 26
$1.40
Q4 25
$0.06
$1.54
Q3 25
$0.04
$1.62
Q2 25
$0.04
$1.38
Q1 25
$-0.04
$1.33
Q4 24
$0.00
$1.35
Q3 24
$-0.04
$1.34
Q2 24
$-0.14
$1.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCLD
CCLD
ESQ
ESQ
Cash + ST InvestmentsLiquidity on hand
$222.2M
Total DebtLower is stronger
$1.2M
Stockholders' EquityBook value
$59.5M
$301.3M
Total Assets
$87.6M
$2.4B
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCLD
CCLD
ESQ
ESQ
Q1 26
$222.2M
Q4 25
$235.9M
Q3 25
$240.8M
Q2 25
$163.0M
Q1 25
$173.0M
Q4 24
$126.3M
Q3 24
$147.7M
Q2 24
$152.7M
Total Debt
CCLD
CCLD
ESQ
ESQ
Q1 26
Q4 25
$1.2M
Q3 25
Q2 25
Q1 25
Q4 24
$336.0K
Q3 24
Q2 24
Stockholders' Equity
CCLD
CCLD
ESQ
ESQ
Q1 26
$301.3M
Q4 25
$59.5M
$289.6M
Q3 25
$57.8M
$279.2M
Q2 25
$56.1M
$263.6M
Q1 25
$54.2M
$250.7M
Q4 24
$49.8M
$237.1M
Q3 24
$46.5M
$232.6M
Q2 24
$43.2M
$217.4M
Total Assets
CCLD
CCLD
ESQ
ESQ
Q1 26
$2.4B
Q4 25
$87.6M
$2.4B
Q3 25
$90.6M
$2.2B
Q2 25
$75.2M
$2.1B
Q1 25
$73.6M
$2.0B
Q4 24
$71.6M
$1.9B
Q3 24
$70.7M
$1.8B
Q2 24
$74.0M
$1.7B
Debt / Equity
CCLD
CCLD
ESQ
ESQ
Q1 26
Q4 25
0.02×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCLD
CCLD
ESQ
ESQ
Operating Cash FlowLast quarter
$8.7M
Free Cash FlowOCF − Capex
$6.6M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
6.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCLD
CCLD
ESQ
ESQ
Q1 26
Q4 25
$8.7M
$59.8M
Q3 25
$7.4M
$16.8M
Q2 25
$7.4M
$10.5M
Q1 25
$5.1M
$15.8M
Q4 24
$5.2M
$42.2M
Q3 24
$7.1M
$10.5M
Q2 24
$4.3M
$7.2M
Free Cash Flow
CCLD
CCLD
ESQ
ESQ
Q1 26
Q4 25
$6.6M
$56.7M
Q3 25
$6.5M
$16.2M
Q2 25
$6.2M
$9.3M
Q1 25
$4.5M
$14.7M
Q4 24
$4.3M
$41.5M
Q3 24
$6.7M
$10.5M
Q2 24
$4.2M
$6.9M
FCF Margin
CCLD
CCLD
ESQ
ESQ
Q1 26
Q4 25
19.0%
143.9%
Q3 25
20.9%
43.2%
Q2 25
22.8%
26.0%
Q1 25
16.2%
43.4%
Q4 24
15.2%
125.5%
Q3 24
23.6%
32.8%
Q2 24
14.8%
22.5%
Capex Intensity
CCLD
CCLD
ESQ
ESQ
Q1 26
Q4 25
6.2%
8.0%
Q3 25
2.8%
1.3%
Q2 25
4.2%
3.2%
Q1 25
2.3%
3.4%
Q4 24
3.3%
2.2%
Q3 24
1.2%
0.2%
Q2 24
0.5%
1.1%
Cash Conversion
CCLD
CCLD
ESQ
ESQ
Q1 26
Q4 25
4.44×
Q3 25
2.41×
1.19×
Q2 25
2.55×
0.88×
Q1 25
2.62×
1.39×
Q4 24
3.59×
Q3 24
2.26×
0.93×
Q2 24
2.56×
0.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCLD
CCLD

Healthcare IT$31.0M90%
Medical Practice Management$3.4M10%

ESQ
ESQ

Net Interest Income$34.0M84%
Noninterest Income$6.5M16%

Related Comparisons